Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Glaucoma is one of the neurodegenerative disorders and the leading cause of blindness in Japan. In our previous study, apolipoprotein E-containing lipoproteins strongly protect primary cultured retinal ganglion cells from glutamate-induced neurodegeneration. Here, we determined a novel neuroprotective mechanism of apolipoprotein E-containing lipoproteins and defined roles of an inhibitory factor against the protective effect of apolipoprotein E-containing lipoproteins.
|